Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial
Obesity is a risk factor for cancer. Intentional weight loss in the obese might protect against malignancy, but evidence is limited. To our knowledge, the Swedish Obese Subjects (SOS) study is the first intervention trial in the obese population to provide prospective, controlled cancer-incidence da...
Uloženo v:
| Vydáno v: | The lancet oncology Ročník 10; číslo 7; s. 653 - 662 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
Elsevier Ltd
01.07.2009
Elsevier Limited |
| Témata: | |
| ISSN: | 1470-2045, 1474-5488, 1474-5488 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Obesity is a risk factor for cancer. Intentional weight loss in the obese might protect against malignancy, but evidence is limited. To our knowledge, the Swedish Obese Subjects (SOS) study is the first intervention trial in the obese population to provide prospective, controlled cancer-incidence data.
The SOS study started in 1987 and involved 2010 obese patients (body-mass index [BMI] ≥34 kg/m
2 in men, and ≥38 kg/m
2 in women) who underwent bariatric surgery and 2037 contemporaneously matched obese controls, who received conventional treatment. While the main endpoint of SOS was overall mortality, the main outcome of this exploratory report was cancer incidence until Dec 31, 2005. Cancer follow-up rate was 99·9% and the median follow-up time was 10·9 years (range 0–18·1 years).
Bariatric surgery resulted in a sustained mean weight reduction of 19·9 kg (SD 15·6 kg) over 10 years, whereas the mean weight change in controls was a gain of 1·3 kg (SD 13·7 kg). The number of first-time cancers after inclusion was lower in the surgery group (n=117) than in the control group (n=169; HR 0·67, 95% CI 0·53–0·85, p=0·0009). The sex–treatment interaction p value was 0·054. In women, the number of first-time cancers after inclusion was lower in the surgery group (n=79) than in the control group (n=130; HR 0·58, 0·44–0·77; p=0·0001), whereas there was no effect of surgery in men (38 in the surgery group
vs 39 in the control group; HR 0·97, 0·62–1·52; p=0·90). Similar results were obtained after exclusion of all cancer cases during the first 3 years of the intervention.
Bariatric surgery was associated with reduced cancer incidence in obese women but not in obese men.
Swedish Research Council, Swedish Foundation for Strategic Research, Swedish Federal Government under the LUA/ALF agreement, Hoffmann La Roche, Cederoths, AstraZeneca, Sanofi-Aventis, Ethicon Endosurgery. |
|---|---|
| AbstractList | Obesity is a risk factor for cancer. Intentional weight loss in the obese might protect against malignancy, but evidence is limited. To our knowledge, the Swedish Obese Subjects (SOS) study is the first intervention trial in the obese population to provide prospective, controlled cancer-incidence data.
The SOS study started in 1987 and involved 2010 obese patients (body-mass index [BMI] ≥34 kg/m
2 in men, and ≥38 kg/m
2 in women) who underwent bariatric surgery and 2037 contemporaneously matched obese controls, who received conventional treatment. While the main endpoint of SOS was overall mortality, the main outcome of this exploratory report was cancer incidence until Dec 31, 2005. Cancer follow-up rate was 99·9% and the median follow-up time was 10·9 years (range 0–18·1 years).
Bariatric surgery resulted in a sustained mean weight reduction of 19·9 kg (SD 15·6 kg) over 10 years, whereas the mean weight change in controls was a gain of 1·3 kg (SD 13·7 kg). The number of first-time cancers after inclusion was lower in the surgery group (n=117) than in the control group (n=169; HR 0·67, 95% CI 0·53–0·85, p=0·0009). The sex–treatment interaction p value was 0·054. In women, the number of first-time cancers after inclusion was lower in the surgery group (n=79) than in the control group (n=130; HR 0·58, 0·44–0·77; p=0·0001), whereas there was no effect of surgery in men (38 in the surgery group
vs 39 in the control group; HR 0·97, 0·62–1·52; p=0·90). Similar results were obtained after exclusion of all cancer cases during the first 3 years of the intervention.
Bariatric surgery was associated with reduced cancer incidence in obese women but not in obese men.
Swedish Research Council, Swedish Foundation for Strategic Research, Swedish Federal Government under the LUA/ALF agreement, Hoffmann La Roche, Cederoths, AstraZeneca, Sanofi-Aventis, Ethicon Endosurgery. Obesity is a risk factor for cancer. Intentional weight loss in the obese might protect against malignancy, but evidence is limited. To our knowledge, the Swedish Obese Subjects (SOS) study is the first intervention trial in the obese population to provide prospective, controlled cancer-incidence data. The SOS study started in 1987 and involved 2010 obese patients (body-mass index [BMI] >or=34 kg/m(2) in men, and >or=38 kg/m(2) in women) who underwent bariatric surgery and 2037 contemporaneously matched obese controls, who received conventional treatment. While the main endpoint of SOS was overall mortality, the main outcome of this exploratory report was cancer incidence until Dec 31, 2005. Cancer follow-up rate was 99.9% and the median follow-up time was 10.9 years (range 0-18.1 years). Bariatric surgery resulted in a sustained mean weight reduction of 19.9 kg (SD 15.6 kg) over 10 years, whereas the mean weight change in controls was a gain of 1.3 kg (SD 13.7 kg). The number of first-time cancers after inclusion was lower in the surgery group (n=117) than in the control group (n=169; HR 0.67, 95% CI 0.53-0.85, p=0.0009). The sex-treatment interaction p value was 0.054. In women, the number of first-time cancers after inclusion was lower in the surgery group (n=79) than in the control group (n=130; HR 0.58, 0.44-0.77; p=0.0001), whereas there was no effect of surgery in men (38 in the surgery group vs 39 in the control group; HR 0.97, 0.62-1.52; p=0.90). Similar results were obtained after exclusion of all cancer cases during the first 3 years of the intervention. Bariatric surgery was associated with reduced cancer incidence in obese women but not in obese men. Swedish Research Council, Swedish Foundation for Strategic Research, Swedish Federal Government under the LUA/ALF agreement, Hoffmann La Roche, Cederoths, AstraZeneca, Sanofi-Aventis, Ethicon Endosurgery. BACKGROUND: Obesity is a risk factor for cancer. Intentional weight loss in the obese might protect against malignancy, but evidence is limited. To our knowledge, the Swedish Obese Subjects (SOS) study is the first intervention trial in the obese population to provide prospective, controlled cancer-incidence data. METHODS: The SOS study started in 1987 and involved 2010 obese patients (body-mass index [BMI] >or=34 kg/m(2) in men, and >or=38 kg/m(2) in women) who underwent bariatric surgery and 2037 contemporaneously matched obese controls, who received conventional treatment. While the main endpoint of SOS was overall mortality, the main outcome of this exploratory report was cancer incidence until Dec 31, 2005. Cancer follow-up rate was 99.9% and the median follow-up time was 10.9 years (range 0-18.1 years). FINDINGS: Bariatric surgery resulted in a sustained mean weight reduction of 19.9 kg (SD 15.6 kg) over 10 years, whereas the mean weight change in controls was a gain of 1.3 kg (SD 13.7 kg). The number of first-time cancers after inclusion was lower in the surgery group (n=117) than in the control group (n=169; HR 0.67, 95% CI 0.53-0.85, p=0.0009). The sex-treatment interaction p value was 0.054. In women, the number of first-time cancers after inclusion was lower in the surgery group (n=79) than in the control group (n=130; HR 0.58, 0.44-0.77; p=0.0001), whereas there was no effect of surgery in men (38 in the surgery group vs 39 in the control group; HR 0.97, 0.62-1.52; p=0.90). Similar results were obtained after exclusion of all cancer cases during the first 3 years of the intervention. INTERPRETATION: Bariatric surgery was associated with reduced cancer incidence in obese women but not in obese men. FUNDING: Swedish Research Council, Swedish Foundation for Strategic Research, Swedish Federal Government under the LUA/ALF agreement, Hoffmann La Roche, Cederoths, AstraZeneca, Sanofi-Aventis, Ethicon Endosurgery. Obesity is a risk factor for cancer. Intentional weight loss in the obese might protect against malignancy, but evidence is limited. To our knowledge, the Swedish Obese Subjects (SOS) study is the first intervention trial in the obese population to provide prospective, controlled cancer-incidence data. The SOS study started in 1987 and involved 2010 obese patients (body-mass index [BMI] >or=34 kg/m(2) in men, and >or=38 kg/m(2) in women) who underwent bariatric surgery and 2037 contemporaneously matched obese controls, who received conventional treatment. While the main endpoint of SOS was overall mortality, the main outcome of this exploratory report was cancer incidence until Dec 31, 2005. Cancer follow-up rate was 99.9% and the median follow-up time was 10.9 years (range 0-18.1 years). Bariatric surgery resulted in a sustained mean weight reduction of 19.9 kg (SD 15.6 kg) over 10 years, whereas the mean weight change in controls was a gain of 1.3 kg (SD 13.7 kg). The number of first-time cancers after inclusion was lower in the surgery group (n=117) than in the control group (n=169; HR 0.67, 95% CI 0.53-0.85, p=0.0009). The sex-treatment interaction p value was 0.054. In women, the number of first-time cancers after inclusion was lower in the surgery group (n=79) than in the control group (n=130; HR 0.58, 0.44-0.77; p=0.0001), whereas there was no effect of surgery in men (38 in the surgery group vs 39 in the control group; HR 0.97, 0.62-1.52; p=0.90). Similar results were obtained after exclusion of all cancer cases during the first 3 years of the intervention. Bariatric surgery was associated with reduced cancer incidence in obese women but not in obese men. Swedish Research Council, Swedish Foundation for Strategic Research, Swedish Federal Government under the LUA/ALF agreement, Hoffmann La Roche, Cederoths, AstraZeneca, Sanofi-Aventis, Ethicon Endosurgery. Summary Background Obesity is a risk factor for cancer. Intentional weight loss in the obese might protect against malignancy, but evidence is limited. To our knowledge, the Swedish Obese Subjects (SOS) study is the first intervention trial in the obese population to provide prospective, controlled cancer-incidence data. Methods The SOS study started in 1987 and involved 2010 obese patients (body-mass index [BMI] ≥34 kg/m2 in men, and ≥38 kg/m2 in women) who underwent bariatric surgery and 2037 contemporaneously matched obese controls, who received conventional treatment. While the main endpoint of SOS was overall mortality, the main outcome of this exploratory report was cancer incidence until Dec 31, 2005. Cancer follow-up rate was 99·9% and the median follow-up time was 10·9 years (range 0–18·1 years). Findings Bariatric surgery resulted in a sustained mean weight reduction of 19·9 kg (SD 15·6 kg) over 10 years, whereas the mean weight change in controls was a gain of 1·3 kg (SD 13·7 kg). The number of first-time cancers after inclusion was lower in the surgery group (n=117) than in the control group (n=169; HR 0·67, 95% CI 0·53–0·85, p=0·0009). The sex–treatment interaction p value was 0·054. In women, the number of first-time cancers after inclusion was lower in the surgery group (n=79) than in the control group (n=130; HR 0·58, 0·44–0·77; p=0·0001), whereas there was no effect of surgery in men (38 in the surgery group vs 39 in the control group; HR 0·97, 0·62–1·52; p=0·90). Similar results were obtained after exclusion of all cancer cases during the first 3 years of the intervention. Interpretation Bariatric surgery was associated with reduced cancer incidence in obese women but not in obese men. Funding Swedish Research Council, Swedish Foundation for Strategic Research, Swedish Federal Government under the LUA/ALF agreement, Hoffmann La Roche, Cederoths, AstraZeneca, Sanofi-Aventis, Ethicon Endosurgery. BACKGROUND: Obesity is a risk factor for cancer. Intentional weight loss in the obese might protect against malignancy, but evidence is limited. To our knowledge, the Swedish Obese Subjects (SOS) study is the first intervention trial in the obese population to provide prospective, controlled cancer-incidence data. METHODS: The SOS study started in 1987 and involved 2010 obese patients (body-mass index [BMI] >or=34 kg/m(2) in men, and >or=38 kg/m(2) in women) who underwent bariatric surgery and 2037 contemporaneously matched obese controls, who received conventional treatment. While the main endpoint of SOS was overall mortality, the main outcome of this exploratory report was cancer incidence until Dec 31, 2005. Cancer follow-up rate was 99.9% and the median follow-up time was 10.9 years (range 0-18.1 years). FINDINGS: Bariatric surgery resulted in a sustained mean weight reduction of 19.9 kg (SD 15.6 kg) over 10 years, whereas the mean weight change in controls was a gain of 1.3 kg (SD 13.7 kg). The number of first-time cancers after inclusion was lower in the surgery group (n=117) than in the control group (n=169; HR 0.67, 95% CI 0.53-0.85, p=0.0009). The sex-treatment interaction p value was 0.054. In women, the number of first-time cancers after inclusion was lower in the surgery group (n=79) than in the control group (n=130; HR 0.58, 0.44-0.77; p=0.0001), whereas there was no effect of surgery in men (38 in the surgery group vs 39 in the control group; HR 0.97, 0.62-1.52; p=0.90). Similar results were obtained after exclusion of all cancer cases during the first 3 years of the intervention. INTERPRETATION: Bariatric surgery was associated with reduced cancer incidence in obese women but not in obese men. FUNDING: Swedish Research Council, Swedish Foundation for Strategic Research, Swedish Federal Government under the LUA/ALF agreement, Hoffmann La Roche, Cederoths, AstraZeneca, Sanofi-Aventis, Ethicon Endosurgery. Obesity is a risk factor for cancer. Intentional weight loss in the obese might protect against malignancy, but evidence is limited. To our knowledge, the Swedish Obese Subjects (SOS) study is the first intervention trial in the obese population to provide prospective, controlled cancer-incidence data.BACKGROUNDObesity is a risk factor for cancer. Intentional weight loss in the obese might protect against malignancy, but evidence is limited. To our knowledge, the Swedish Obese Subjects (SOS) study is the first intervention trial in the obese population to provide prospective, controlled cancer-incidence data.The SOS study started in 1987 and involved 2010 obese patients (body-mass index [BMI] >or=34 kg/m(2) in men, and >or=38 kg/m(2) in women) who underwent bariatric surgery and 2037 contemporaneously matched obese controls, who received conventional treatment. While the main endpoint of SOS was overall mortality, the main outcome of this exploratory report was cancer incidence until Dec 31, 2005. Cancer follow-up rate was 99.9% and the median follow-up time was 10.9 years (range 0-18.1 years).METHODSThe SOS study started in 1987 and involved 2010 obese patients (body-mass index [BMI] >or=34 kg/m(2) in men, and >or=38 kg/m(2) in women) who underwent bariatric surgery and 2037 contemporaneously matched obese controls, who received conventional treatment. While the main endpoint of SOS was overall mortality, the main outcome of this exploratory report was cancer incidence until Dec 31, 2005. Cancer follow-up rate was 99.9% and the median follow-up time was 10.9 years (range 0-18.1 years).Bariatric surgery resulted in a sustained mean weight reduction of 19.9 kg (SD 15.6 kg) over 10 years, whereas the mean weight change in controls was a gain of 1.3 kg (SD 13.7 kg). The number of first-time cancers after inclusion was lower in the surgery group (n=117) than in the control group (n=169; HR 0.67, 95% CI 0.53-0.85, p=0.0009). The sex-treatment interaction p value was 0.054. In women, the number of first-time cancers after inclusion was lower in the surgery group (n=79) than in the control group (n=130; HR 0.58, 0.44-0.77; p=0.0001), whereas there was no effect of surgery in men (38 in the surgery group vs 39 in the control group; HR 0.97, 0.62-1.52; p=0.90). Similar results were obtained after exclusion of all cancer cases during the first 3 years of the intervention.FINDINGSBariatric surgery resulted in a sustained mean weight reduction of 19.9 kg (SD 15.6 kg) over 10 years, whereas the mean weight change in controls was a gain of 1.3 kg (SD 13.7 kg). The number of first-time cancers after inclusion was lower in the surgery group (n=117) than in the control group (n=169; HR 0.67, 95% CI 0.53-0.85, p=0.0009). The sex-treatment interaction p value was 0.054. In women, the number of first-time cancers after inclusion was lower in the surgery group (n=79) than in the control group (n=130; HR 0.58, 0.44-0.77; p=0.0001), whereas there was no effect of surgery in men (38 in the surgery group vs 39 in the control group; HR 0.97, 0.62-1.52; p=0.90). Similar results were obtained after exclusion of all cancer cases during the first 3 years of the intervention.Bariatric surgery was associated with reduced cancer incidence in obese women but not in obese men.INTERPRETATIONBariatric surgery was associated with reduced cancer incidence in obese women but not in obese men.Swedish Research Council, Swedish Foundation for Strategic Research, Swedish Federal Government under the LUA/ALF agreement, Hoffmann La Roche, Cederoths, AstraZeneca, Sanofi-Aventis, Ethicon Endosurgery.FUNDINGSwedish Research Council, Swedish Foundation for Strategic Research, Swedish Federal Government under the LUA/ALF agreement, Hoffmann La Roche, Cederoths, AstraZeneca, Sanofi-Aventis, Ethicon Endosurgery. |
| Author | Bouchard, Claude Jacobson, Peter Narbro, Kristina Lindroos, Anna-Karin Näslund, Ingmar Karason, Kristjan Torgerson, Jarl Dahlgren, Sven Sjöström, Lars Lönroth, Hans Stenlöf, Kaj Larsson, Bo Wedel, Hans Carlsson, Björn Carlsson, Lena MS Gummesson, Anders Olbers, Torsten Karlsson, Jan Sjöström, C David Bengtsson, Calle Peltonen, Markku |
| Author_xml | – sequence: 1 givenname: Lars surname: Sjöström fullname: Sjöström, Lars email: lars.v.sjostrom@medfak.gu.se organization: The Institutes of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden – sequence: 2 givenname: Anders surname: Gummesson fullname: Gummesson, Anders organization: The Institutes of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden – sequence: 3 givenname: C David surname: Sjöström fullname: Sjöström, C David organization: Anesthesiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden – sequence: 4 givenname: Kristina surname: Narbro fullname: Narbro, Kristina organization: Department of Health Care, Regional Secretariat, Västra Götaland Region, Gothenburg, Sweden – sequence: 5 givenname: Markku surname: Peltonen fullname: Peltonen, Markku organization: Diabetes Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland – sequence: 6 givenname: Hans surname: Wedel fullname: Wedel, Hans organization: Nordic School of Public Health, Gothenburg, Sweden – sequence: 7 givenname: Calle surname: Bengtsson fullname: Bengtsson, Calle organization: Primary Health Care, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden – sequence: 8 givenname: Claude surname: Bouchard fullname: Bouchard, Claude organization: Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA, USA – sequence: 9 givenname: Björn surname: Carlsson fullname: Carlsson, Björn organization: The Institutes of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden – sequence: 10 givenname: Sven surname: Dahlgren fullname: Dahlgren, Sven organization: Department of Surgery, Umeå University, Umeå, Sweden – sequence: 11 givenname: Peter surname: Jacobson fullname: Jacobson, Peter organization: The Institutes of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden – sequence: 12 givenname: Kristjan surname: Karason fullname: Karason, Kristjan organization: Cardiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden – sequence: 13 givenname: Jan surname: Karlsson fullname: Karlsson, Jan organization: Health and Care Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden – sequence: 14 givenname: Bo surname: Larsson fullname: Larsson, Bo organization: Anesthesiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden – sequence: 15 givenname: Anna-Karin surname: Lindroos fullname: Lindroos, Anna-Karin organization: Medical Research Council Human Nutrition Research, Elsie Widdowson Laboratory, Cambridge, UK – sequence: 16 givenname: Hans surname: Lönroth fullname: Lönroth, Hans organization: Surgery, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden – sequence: 17 givenname: Ingmar surname: Näslund fullname: Näslund, Ingmar organization: Department of Surgery, University Hospital, Örebro, Sweden – sequence: 18 givenname: Torsten surname: Olbers fullname: Olbers, Torsten organization: Surgery, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden – sequence: 19 givenname: Kaj surname: Stenlöf fullname: Stenlöf, Kaj organization: The Institutes of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden – sequence: 20 givenname: Jarl surname: Torgerson fullname: Torgerson, Jarl organization: Department of Health Care, Regional Secretariat, Västra Götaland Region, Gothenburg, Sweden – sequence: 21 givenname: Lena MS surname: Carlsson fullname: Carlsson, Lena MS organization: The Institutes of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19556163$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-25354$$DView record from Swedish Publication Index (Umeå universitet) https://gup.ub.gu.se/publication/119376$$DView record from Swedish Publication Index (Göteborgs universitet) |
| BookMark | eNqNkttu1DAQhiNURA_wCCCLC9RKDdibOIlBgKpSDlKlXixwa9nOZPGSjYMdb7WPwtsyyZYirVSVK4_G3_zj8fyHyV7nOkiSp4y-ZJQVr-YsL2k6ozk_puKkpIyLtHyQHGA6T3leVXtTvEX2k8MQlpSyklH-KNlngvOCFdlB8vuiacAMgbiGaOWtGrw1JES_AL8hriNGdQY8sZ2xNWCIEXEaApBeDRY6LMXM_BrwlhyPpw0_yNVEzKNeTuLzIdabk9dEkd670GPOruGUGNcN3rUt1KgxgF-jnMWe-AbVPk4eNqoN8OTmPEq-fbz4ev45vbz69OX87DI1RU6HNBdClE1NtSprrUTGdYEDa8GgyUqV6VoXqigo5LmpBG9YzRulM5ydVY2oKpMdJelWN1xDH7XsvV0pv5FOWbmIvcTUIsoAkjGRlQXyp3fyH-z3M-n8QsZVlDOe8RzxF1scJ_8VIQxyZYOBtlUduBhkUeZ8RmmJ4PMdcOmi73B0ifeCiqqkCD27gaJeQX3b_O9CEeBbwOBHBw_NP4TK0ThyMo4cXSGpkJNx5Nj9zU6dsYMatzF4Zdt7q99vqwEXtbbgZTB2dEttPS5b1s7eq_BuR8G0trNGtT9hA-H2K5gMM0m3IqMGFZPCKPD2boH_eMAf44UG9w |
| CODEN | LANCAO |
| CitedBy_id | crossref_primary_10_1016_j_maturitas_2013_12_004 crossref_primary_10_1007_s10654_025_01237_6 crossref_primary_10_1093_jncimonographs_lgad003 crossref_primary_10_1016_j_cireng_2013_02_001 crossref_primary_10_1016_j_canlet_2017_12_019 crossref_primary_10_1016_j_cophys_2019_09_002 crossref_primary_10_1007_s12020_013_9983_1 crossref_primary_10_1038_s41579_020_0438_4 crossref_primary_10_1016_j_mcna_2017_08_011 crossref_primary_10_1146_annurev_med_051613_012328 crossref_primary_10_2337_dc18_S007 crossref_primary_10_1016_j_soard_2014_03_022 crossref_primary_10_1017_S0029665109991698 crossref_primary_10_1371_journal_pone_0202651 crossref_primary_10_3390_biomedicines10061284 crossref_primary_10_1016_j_soard_2014_03_023 crossref_primary_10_1007_s11695_017_3010_1 crossref_primary_10_2337_dc23_S008 crossref_primary_10_1016_j_gassur_2024_01_028 crossref_primary_10_1093_jnci_djaf201 crossref_primary_10_1007_s11695_016_2144_x crossref_primary_10_1080_17446651_2019_1628639 crossref_primary_10_1111_imr_12856 crossref_primary_10_1007_s11695_010_0144_9 crossref_primary_10_1016_j_gie_2015_08_007 crossref_primary_10_1111_ases_12048 crossref_primary_10_1186_s13148_016_0177_6 crossref_primary_10_1159_000507087 crossref_primary_10_1111_joim_12837 crossref_primary_10_1016_j_ygyno_2011_12_439 crossref_primary_10_3945_ajcn_115_110536 crossref_primary_10_1007_s00108_014_3534_6 crossref_primary_10_1016_j_cmet_2015_02_005 crossref_primary_10_1016_j_ygyno_2017_02_036 crossref_primary_10_2337_dc19_1909 crossref_primary_10_1002_oby_23161 crossref_primary_10_1038_s41467_018_06571_w crossref_primary_10_1007_s00464_018_6472_x crossref_primary_10_1111_apt_16335 crossref_primary_10_1371_journal_pone_0248550 crossref_primary_10_1007_s10728_012_0216_1 crossref_primary_10_1007_s11695_017_2901_5 crossref_primary_10_1200_JCO_2016_66_8806 crossref_primary_10_1007_s13668_014_0105_3 crossref_primary_10_1016_j_soard_2017_01_027 crossref_primary_10_1038_ijo_2012_107 crossref_primary_10_1097_SLE_0000000000000050 crossref_primary_10_3390_nu12113354 crossref_primary_10_1007_s11695_023_06883_x crossref_primary_10_1016_j_mcna_2017_08_004 crossref_primary_10_1111_cas_12077 crossref_primary_10_1002_oby_23158 crossref_primary_10_1016_j_ygyno_2015_05_015 crossref_primary_10_2337_dcS15_3018 crossref_primary_10_1007_s11695_023_06674_4 crossref_primary_10_1007_s11695_012_0798_6 crossref_primary_10_1016_j_ejso_2022_11_013 crossref_primary_10_1097_MPA_0000000000000974 crossref_primary_10_1016_j_diabres_2023_110667 crossref_primary_10_1007_s00104_013_2582_0 crossref_primary_10_1007_s00464_022_09656_2 crossref_primary_10_1371_journal_pone_0162189 crossref_primary_10_1016_j_soard_2020_07_017 crossref_primary_10_1016_j_mam_2017_04_001 crossref_primary_10_1186_s12933_016_0347_z crossref_primary_10_1007_s11695_014_1526_1 crossref_primary_10_1038_s41366_021_00866_7 crossref_primary_10_1093_eurheartj_ehac388 crossref_primary_10_1200_JCO_2011_38_5500 crossref_primary_10_1097_SLA_0000000000005035 crossref_primary_10_1158_1940_6207_CAPR_12_0034 crossref_primary_10_3390_ijms23126703 crossref_primary_10_1186_s12979_017_0112_5 crossref_primary_10_1016_j_canep_2025_102837 crossref_primary_10_1111_j_1467_789X_2011_00866_x crossref_primary_10_1373_jalm_2018_028613 crossref_primary_10_1155_2013_697521 crossref_primary_10_1016_S1470_2045_09_70170_6 crossref_primary_10_1007_s11695_021_05511_w crossref_primary_10_3322_caac_21499 crossref_primary_10_2337_dc11_s253 crossref_primary_10_1111_1753_0407_13179 crossref_primary_10_1007_s11695_023_06926_3 crossref_primary_10_1007_s12170_010_0136_2 crossref_primary_10_1002_lt_26074 crossref_primary_10_1007_s11695_019_03910_8 crossref_primary_10_1016_j_canep_2011_03_001 crossref_primary_10_1371_journal_pone_0258545 crossref_primary_10_1016_j_soard_2024_10_023 crossref_primary_10_1002_oby_20821 crossref_primary_10_1016_j_thorsurg_2017_08_006 crossref_primary_10_1016_j_jacc_2017_12_014 crossref_primary_10_1007_s10549_013_2730_8 crossref_primary_10_1002_cncr_25738 crossref_primary_10_3389_fendo_2020_00213 crossref_primary_10_1016_j_surg_2019_03_013 crossref_primary_10_2478_v10035_012_0065_5 crossref_primary_10_1200_JCO_2016_70_5822 crossref_primary_10_1016_j_soard_2016_05_018 crossref_primary_10_1038_nrendo_2009_164 crossref_primary_10_1007_s10620_019_05603_9 crossref_primary_10_1016_j_soard_2011_05_013 crossref_primary_10_1016_j_soard_2013_10_007 crossref_primary_10_31146_1682_8658_ecg_218_10_5_47 crossref_primary_10_1038_nrclinonc_2016_120 crossref_primary_10_1093_jnci_djt223 crossref_primary_10_1016_j_soard_2014_02_040 crossref_primary_10_1016_j_ejim_2018_05_033 crossref_primary_10_1007_s00464_019_06988_4 crossref_primary_10_1634_theoncologist_2009_0285 crossref_primary_10_1111_ans_19206 crossref_primary_10_1007_s40615_018_00546_9 crossref_primary_10_3389_fnut_2016_00025 crossref_primary_10_1016_j_ejso_2025_110358 crossref_primary_10_1038_471S16a crossref_primary_10_1016_j_ajog_2011_05_042 crossref_primary_10_1111_imj_14226 crossref_primary_10_1007_s11695_016_2321_y crossref_primary_10_2337_dc19_S008 crossref_primary_10_2337_dc22_S008 crossref_primary_10_1080_13697137_2017_1262638 crossref_primary_10_12688_f1000research_13515_1 crossref_primary_10_1007_s11695_013_1164_z crossref_primary_10_1007_s00125_011_2169_6 crossref_primary_10_1155_2013_291546 crossref_primary_10_1089_bari_2021_0104 crossref_primary_10_1016_j_orcp_2010_11_005 crossref_primary_10_1002_oby_22936 crossref_primary_10_3390_nu17142310 crossref_primary_10_1016_j_pharmthera_2023_108442 crossref_primary_10_2217_dmt_13_76 crossref_primary_10_1016_j_semnephrol_2012_12_004 crossref_primary_10_1158_1940_6207_CAPR_24_0514 crossref_primary_10_1007_s12328_019_00953_3 crossref_primary_10_1016_j_psc_2019_01_014 crossref_primary_10_1007_s11695_010_0250_8 crossref_primary_10_1016_j_gore_2018_04_004 crossref_primary_10_1136_ijgc_2019_000728 crossref_primary_10_2337_dc16_0236 crossref_primary_10_1016_j_clbc_2017_10_010 crossref_primary_10_1136_gutjnl_2013_304701 crossref_primary_10_1053_j_gastro_2016_03_004 crossref_primary_10_1016_j_ygyno_2017_07_144 crossref_primary_10_1007_s11695_014_1276_0 crossref_primary_10_1530_EJE_16_0906 crossref_primary_10_1038_s41598_020_77285_7 crossref_primary_10_2337_dc16_0350 crossref_primary_10_1530_JOE_18_0182 crossref_primary_10_1016_j_jand_2017_07_005 crossref_primary_10_1111_j_1464_5491_2011_03306_x crossref_primary_10_1007_s11695_023_06477_7 crossref_primary_10_2337_dc09_1183 crossref_primary_10_1371_journal_pmed_1001925 crossref_primary_10_1038_s41575_019_0209_8 crossref_primary_10_1111_cob_12007 crossref_primary_10_3390_ijms24076192 crossref_primary_10_1007_s11606_011_1721_x crossref_primary_10_1093_jncics_pkz054 crossref_primary_10_1186_s12902_017_0202_6 crossref_primary_10_1097_MCO_0b013e3283468e50 crossref_primary_10_1016_j_orcp_2019_01_001 crossref_primary_10_2217_dmt_15_32 crossref_primary_10_1016_j_ajog_2015_05_015 crossref_primary_10_1097_AOG_0000000000001975 crossref_primary_10_1016_j_canep_2018_01_002 crossref_primary_10_1007_s11695_021_05331_y crossref_primary_10_1016_j_arr_2013_05_007 crossref_primary_10_1002_ijc_24803 crossref_primary_10_1016_j_metabol_2018_10_013 crossref_primary_10_1177_0004563215588116 crossref_primary_10_1177_1756283X13501786 crossref_primary_10_1158_1940_6207_CAPR_15_0061 crossref_primary_10_1016_j_soard_2017_04_029 crossref_primary_10_3945_an_113_004341 crossref_primary_10_1016_j_ccell_2023_05_010 crossref_primary_10_1111_1471_0528_12106 crossref_primary_10_1007_s00464_013_3127_9 crossref_primary_10_3389_fsurg_2022_1110401 crossref_primary_10_1016_j_soard_2015_09_016 crossref_primary_10_1038_s41590_018_0251_7 crossref_primary_10_1007_s11695_012_0595_2 crossref_primary_10_1016_j_coph_2013_09_005 crossref_primary_10_3390_nu17010178 crossref_primary_10_1007_s13105_024_01048_5 crossref_primary_10_1200_JCO_2010_27_9935 crossref_primary_10_4103_ijo_IJO_295_20 crossref_primary_10_1002_oby_20660 crossref_primary_10_1186_s12893_015_0072_7 crossref_primary_10_1001_jamadermatol_2019_3240 crossref_primary_10_3322_caac_21405 crossref_primary_10_1007_s11883_013_0367_z crossref_primary_10_1016_j_soard_2013_07_019 crossref_primary_10_1016_j_soard_2014_09_024 crossref_primary_10_1007_s12072_012_9406_z crossref_primary_10_1161_CIRCRESAHA_116_307591 crossref_primary_10_5867_medwave_2012_07_5462 crossref_primary_10_3390_cancers16223730 crossref_primary_10_1016_j_ejogrb_2023_06_028 crossref_primary_10_1080_14656566_2024_2436595 crossref_primary_10_2337_dcS13_2040 crossref_primary_10_1038_cddis_2015_381 crossref_primary_10_1007_s00464_013_3358_9 crossref_primary_10_1038_ijo_2011_189 crossref_primary_10_3389_fendo_2014_00065 crossref_primary_10_1002_oby_23800 crossref_primary_10_1007_s10552_011_9730_y crossref_primary_10_1016_j_orcp_2011_07_002 crossref_primary_10_1002_oby_22719 crossref_primary_10_1517_14740338_2013_806481 crossref_primary_10_1016_j_soard_2014_08_012 crossref_primary_10_1097_TP_0000000000003867 crossref_primary_10_2337_dc21_1335 crossref_primary_10_1016_j_soard_2023_11_010 crossref_primary_10_1080_03630242_2022_2066747 crossref_primary_10_1586_17446651_2015_1077696 crossref_primary_10_1007_s11695_012_0780_3 crossref_primary_10_1017_S0007114512004631 crossref_primary_10_1038_s41575_018_0053_2 crossref_primary_10_1007_s11695_020_04481_9 crossref_primary_10_1007_s11695_017_3099_2 crossref_primary_10_1097_SLA_0000000000003331 crossref_primary_10_1038_bjc_2016_37 crossref_primary_10_1056_NEJMc1211380 crossref_primary_10_2337_dc24_S008 crossref_primary_10_1038_ijo_2010_282 crossref_primary_10_1146_annurev_pathol_012615_044359 crossref_primary_10_1186_1741_7015_11_8 crossref_primary_10_1089_bar_2010_9995 crossref_primary_10_3390_curroncol32060362 crossref_primary_10_4093_dmj_2014_38_6_406 crossref_primary_10_1111_1471_0528_13684 crossref_primary_10_1111_tog_12601 crossref_primary_10_1016_j_suc_2011_08_010 crossref_primary_10_1097_MPA_0000000000001037 crossref_primary_10_1111_apt_12872 crossref_primary_10_1136_ijgc_2020_001309 crossref_primary_10_1038_ijo_2010_166 crossref_primary_10_1152_physrev_00030_2014 crossref_primary_10_1111_joim_12012 crossref_primary_10_1007_s00125_016_3903_x crossref_primary_10_1016_j_clnu_2023_03_021 crossref_primary_10_1089_bari_2014_0038 crossref_primary_10_1186_s40608_016_0134_0 crossref_primary_10_1007_s00129_011_2834_3 crossref_primary_10_1007_s11695_018_3151_x crossref_primary_10_1038_s41416_021_01393_y crossref_primary_10_1038_nrgastro_2016_139 crossref_primary_10_1007_s11695_018_03701_7 crossref_primary_10_1111_nyas_12416 crossref_primary_10_1016_j_soard_2021_06_005 crossref_primary_10_1097_SLA_0b013e318288463a crossref_primary_10_1007_s10549_017_4361_y crossref_primary_10_1038_s41575_018_0057_y crossref_primary_10_1111_j_1467_789X_2010_00831_x crossref_primary_10_3390_ijms23063404 crossref_primary_10_1038_bmt_2012_201 crossref_primary_10_1146_annurev_food_041715_033159 crossref_primary_10_1016_j_soard_2022_08_013 crossref_primary_10_1097_AOG_0000000000004989 crossref_primary_10_3390_ijms19010028 crossref_primary_10_1016_j_drudis_2017_04_009 crossref_primary_10_1093_jnci_djz226 crossref_primary_10_1016_j_soard_2023_02_016 crossref_primary_10_1111_j_1463_1326_2011_01464_x crossref_primary_10_1007_s11695_018_3501_8 crossref_primary_10_1161_CIRCULATIONAHA_111_023499 crossref_primary_10_1007_s11695_016_2457_9 crossref_primary_10_1136_bmjopen_2022_061509 crossref_primary_10_1186_1472_6963_10_284 crossref_primary_10_1007_s11695_014_1488_3 crossref_primary_10_1053_j_gastro_2020_06_006 crossref_primary_10_1007_s11695_021_05879_9 crossref_primary_10_1016_S2213_8587_13_70062_7 crossref_primary_10_1038_ijo_2013_24 crossref_primary_10_1007_s11695_012_0832_8 crossref_primary_10_1007_s11883_016_0592_3 crossref_primary_10_1007_s11695_020_04751_6 crossref_primary_10_1007_s11695_016_2421_8 crossref_primary_10_1586_17446651_2015_1073586 crossref_primary_10_1016_j_soard_2018_07_024 crossref_primary_10_1111_j_1467_789X_2012_01010_x crossref_primary_10_1016_j_metabol_2018_12_002 crossref_primary_10_1016_j_suc_2020_12_003 crossref_primary_10_1038_nrendo_2011_10 crossref_primary_10_1080_14779072_2017_1352471 crossref_primary_10_1016_j_ejogrb_2017_04_015 crossref_primary_10_1007_s11695_022_06332_1 crossref_primary_10_1016_S0140_6736_24_01210_8 crossref_primary_10_3389_fnut_2022_918330 crossref_primary_10_1017_S0029665110001515 crossref_primary_10_2337_dc15_1407 crossref_primary_10_1136_annrheumdis_2016_209958 crossref_primary_10_1053_j_gastro_2017_01_051 crossref_primary_10_3390_biom12121827 crossref_primary_10_1038_s41575_018_0069_7 crossref_primary_10_1016_j_jchirv_2017_07_083 crossref_primary_10_3389_fonc_2021_717242 crossref_primary_10_1155_2012_768247 crossref_primary_10_1007_s11695_016_2431_6 crossref_primary_10_1017_S002966511100320X crossref_primary_10_1007_s11695_017_2642_5 crossref_primary_10_1093_crocol_otac013 crossref_primary_10_1007_s11695_019_03798_4 crossref_primary_10_1002_oby_20397 crossref_primary_10_3390_ijms20184397 crossref_primary_10_3390_ijms25137342 crossref_primary_10_1002_lt_25303 crossref_primary_10_1111_1759_7714_15239 crossref_primary_10_1007_s40265_019_1057_0 crossref_primary_10_1007_s00104_018_0662_x crossref_primary_10_1007_s11695_021_05747_6 crossref_primary_10_1038_ni_3754 crossref_primary_10_1634_theoncologist_2010_0206 crossref_primary_10_1016_j_beem_2010_06_001 crossref_primary_10_2337_dc12_1395 crossref_primary_10_1016_j_cmet_2017_04_028 crossref_primary_10_1007_s11695_017_2883_3 crossref_primary_10_1183_09031936_00022111 crossref_primary_10_1007_s11695_021_05626_0 crossref_primary_10_1016_S2213_8587_13_70198_0 crossref_primary_10_1089_bari_2023_0044 crossref_primary_10_3390_toxics13030152 crossref_primary_10_1007_s11690_014_0457_2 crossref_primary_10_1161_01_cir_0000437739_71477_ee crossref_primary_10_1016_j_maturitas_2010_02_011 crossref_primary_10_1080_17482631_2022_2050458 crossref_primary_10_1016_j_pneurobio_2013_12_001 crossref_primary_10_1007_s11695_018_3601_5 crossref_primary_10_1002_oby_20493 crossref_primary_10_1002_oby_23647 crossref_primary_10_1007_s00423_018_1684_z crossref_primary_10_2337_dc17_S010 crossref_primary_10_3389_fonc_2021_627270 crossref_primary_10_3389_fendo_2018_00530 crossref_primary_10_1097_MPA_0000000000000497 crossref_primary_10_1016_j_suc_2011_08_003 crossref_primary_10_1097_SLA_0000000000002525 crossref_primary_10_1016_j_metabol_2018_11_001 crossref_primary_10_1373_clinchem_2017_272336 crossref_primary_10_2337_dc21_S008 crossref_primary_10_1080_16089677_2015_1085700 crossref_primary_10_1111_1753_0407_12057 crossref_primary_10_1002_iid3_538 crossref_primary_10_1007_s00104_017_0381_8 crossref_primary_10_1016_j_soard_2020_06_012 crossref_primary_10_1016_j_soard_2021_08_020 crossref_primary_10_1172_JCI67227 crossref_primary_10_1111_j_1742_1241_2010_02354_x crossref_primary_10_1038_ijo_2011_15 crossref_primary_10_1080_17446651_2022_2110865 crossref_primary_10_1007_s10269_013_2261_2 crossref_primary_10_1016_S0140_6736_12_60401_2 crossref_primary_10_1001_jama_2022_9009 crossref_primary_10_1002_oby_24318 crossref_primary_10_1530_EJE_18_0009 crossref_primary_10_1007_s00464_020_08091_5 crossref_primary_10_1016_j_cpsurg_2024_101549 crossref_primary_10_1016_j_soard_2023_01_027 crossref_primary_10_1016_j_soard_2023_01_028 crossref_primary_10_1136_jclinpath_2012_200798 crossref_primary_10_2337_dc20_S008 crossref_primary_10_3945_ajcn_114_095182 crossref_primary_10_1038_nrgastro_2011_23 crossref_primary_10_4252_wjsc_v15_i4_120 crossref_primary_10_1007_s11695_016_2271_4 crossref_primary_10_1007_s10911_013_9303_7 crossref_primary_10_1001_jama_2022_16518 crossref_primary_10_1002_oby_22002 crossref_primary_10_1007_s11695_016_2415_6 crossref_primary_10_1177_1363459316660858 crossref_primary_10_1016_j_ejca_2010_07_052 crossref_primary_10_1146_annurev_nutr_071714_034434 crossref_primary_10_1080_00365521_2017_1293154 crossref_primary_10_1007_s11695_016_2534_0 crossref_primary_10_1016_j_obpill_2024_100106 crossref_primary_10_1007_s40137_025_00448_w crossref_primary_10_12968_bjon_2015_24_15_776 crossref_primary_10_1016_S1957_2557_19_30209_3 crossref_primary_10_1007_s11695_016_2206_0 crossref_primary_10_1146_annurev_med_080708_082713 crossref_primary_10_1158_1940_6207_CAPR_16_0209 crossref_primary_10_2217_fon_10_87 crossref_primary_10_1007_s11695_018_3191_2 crossref_primary_10_1053_j_gastro_2021_06_003 crossref_primary_10_1007_s00592_019_01433_3 crossref_primary_10_1038_oby_2011_268 crossref_primary_10_1097_SLA_0000000000000431 crossref_primary_10_3390_cancers13133183 crossref_primary_10_1016_j_lpm_2010_01_015 crossref_primary_10_1016_j_critrevonc_2018_01_002 crossref_primary_10_1038_s41423_021_00781_x crossref_primary_10_4158_EP13248_CS crossref_primary_10_1016_j_gtc_2011_09_002 crossref_primary_10_3390_ijms21114030 crossref_primary_10_3892_etm_2016_2973 crossref_primary_10_1016_j_clnu_2022_07_003 crossref_primary_10_1038_s41366_024_01675_4 crossref_primary_10_1007_s11695_022_06155_0 crossref_primary_10_1016_j_soard_2016_08_016 crossref_primary_10_1016_j_soard_2020_04_052 crossref_primary_10_1007_s00104_014_2795_x crossref_primary_10_1016_j_soard_2020_03_019 crossref_primary_10_1007_s11695_016_2051_1 crossref_primary_10_3390_ijms21041241 crossref_primary_10_1007_s11695_021_05778_z crossref_primary_10_7717_peerj_4884 crossref_primary_10_1007_s00125_015_3591_y crossref_primary_10_1016_j_soard_2020_04_047 crossref_primary_10_1007_s11690_014_0427_8 crossref_primary_10_1186_1758_5996_3_12 crossref_primary_10_1016_j_jviscsurg_2018_01_004 crossref_primary_10_1136_postgradmedj_2013_304701rep crossref_primary_10_1016_j_soard_2014_10_013 crossref_primary_10_1210_er_2011_1015 crossref_primary_10_1371_journal_pmed_1003206 crossref_primary_10_2337_ds17_0034 crossref_primary_10_1002_eat_22979 crossref_primary_10_1111_tbj_13430 crossref_primary_10_1056_NEJMoa1112082 crossref_primary_10_1016_j_soard_2014_04_018 crossref_primary_10_3390_cancers12123798 crossref_primary_10_1002_oby_23371 crossref_primary_10_1016_j_soard_2018_02_012 crossref_primary_10_1016_j_mehy_2015_06_022 crossref_primary_10_1002_ijc_31913 crossref_primary_10_1016_S0140_6736_18_30014_X crossref_primary_10_1053_j_gastro_2017_01_035 crossref_primary_10_1016_j_soard_2019_10_025 crossref_primary_10_2337_dc25_S008 crossref_primary_10_1097_SLA_0b013e3181e33778 crossref_primary_10_1038_ijo_2013_205 crossref_primary_10_1111_dom_16263 crossref_primary_10_1016_j_jhep_2019_09_020 crossref_primary_10_1056_NEJMc1612038 crossref_primary_10_1002_hec_3941 crossref_primary_10_4158_GL_2019_0406 crossref_primary_10_1007_s11695_023_06570_x crossref_primary_10_1016_j_jacc_2013_11_004 crossref_primary_10_1053_j_gastro_2013_11_051 crossref_primary_10_1038_ijo_2014_126 crossref_primary_10_1016_j_jpsychores_2014_06_019 crossref_primary_10_1155_2014_810374 crossref_primary_10_3390_biomedicines10082000 crossref_primary_10_1002_oby_23369 crossref_primary_10_1016_j_soard_2015_11_007 crossref_primary_10_1007_s10620_013_2965_6 crossref_primary_10_1007_s11695_019_04028_7 crossref_primary_10_1016_j_tcm_2015_07_006 crossref_primary_10_1016_j_soard_2020_04_012 crossref_primary_10_1007_s00464_023_10386_2 crossref_primary_10_1111_jgh_12293 crossref_primary_10_1155_2023_7429949 crossref_primary_10_1016_j_endoen_2014_12_005 crossref_primary_10_2337_db13_0822 crossref_primary_10_1007_s11695_017_2623_8 crossref_primary_10_1016_j_jval_2016_08_734 crossref_primary_10_1210_jc_2012_2831 crossref_primary_10_1007_s13669_015_0129_8 crossref_primary_10_1016_j_eclinm_2025_103213 crossref_primary_10_1038_nrendo_2015_84 crossref_primary_10_1186_s12933_018_0801_1 crossref_primary_10_1038_s41574_024_01032_5 crossref_primary_10_1093_jn_nxy110 |
| Cites_doi | 10.7326/0003-4819-132-9-200005020-00003 10.1038/oby.2005.217 10.1158/1055-9965.EPI-06-0754 10.1016/j.soard.2008.08.025 10.1056/NEJMoa066254 10.1056/NEJMoa021423 10.1093/jnci/djg022 10.1007/s11095-008-9661-9 10.1016/j.tem.2006.08.006 10.1097/SLA.0b013e3180caa3e3 10.1097/00005082-200304000-00004 10.1007/978-1-60327-492-0_8 10.1111/j.1365-2265.2008.03490.x 10.1038/sj.ijo.0800495 10.1038/oby.2008.610 10.1111/j.1742-7843.2007.00186.x 10.2337/diacare.27.1.155 10.1158/1940-6207.CAPR-08-0003 10.1001/jama.295.6.643 10.1053/j.gastro.2007.03.052 10.1056/NEJMoa066603 10.1093/ajcn/86.3.858S 10.1056/NEJMoa035622 10.1016/S0140-6736(08)60269-X 10.1158/1055-9965.EPI-04-0001 10.1385/ENDO:13:2:213 10.1002/ijc.11277 10.1001/jama.295.6.629 10.1038/sj.ijo.0802437 10.1093/oxfordjournals.aje.a009843 10.1093/oxfordjournals.aje.a117386 |
| ContentType | Journal Article |
| Copyright | 2009 Elsevier Ltd Elsevier Ltd Copyright Elsevier Limited Jul 2009 |
| Copyright_xml | – notice: 2009 Elsevier Ltd – notice: Elsevier Ltd – notice: Copyright Elsevier Limited Jul 2009 |
| CorporateAuthor | for the Swedish Obese Subjects Study Swedish Obese Subjects Study |
| CorporateAuthor_xml | – name: for the Swedish Obese Subjects Study – name: Swedish Obese Subjects Study |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7TO 7X7 7XB 88E 8AO 8C1 8C2 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH H94 K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 ADTPV AOWAS D93 F1U |
| DOI | 10.1016/S1470-2045(09)70159-7 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Oncogenes and Growth Factors Abstracts Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Lancet Titles Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) Medical Database Nursing & Allied Health Premium ProQuest One Academic ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic SwePub SwePub Articles SWEPUB Umeå universitet SWEPUB Göteborgs universitet |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) Lancet Titles ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Oncogenes and Growth Factors Abstracts MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7RV name: Nursing & Allied Health Database url: https://search.proquest.com/nahs sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1474-5488 |
| EndPage | 662 |
| ExternalDocumentID | oai_gup_ub_gu_se_119376 oai_DiVA_org_umu_25354 1777610361 19556163 10_1016_S1470_2045_09_70159_7 S1470204509701597 1_s2_0_S1470204509701597 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Sweden |
| GeographicLocations_xml | – name: Sweden |
| GrantInformation | Swedish Research Council, Swedish Foundation for Strategic Research, Swedish Federal Government under the LUA/ALF agreement, Hoffmann La Roche, Cederoths, AstraZeneca, Sanofi-Aventis, Ethicon Endosurgery. |
| GrantInformation_xml | – fundername: Medical Research Council grantid: MC_U105960389 |
| GroupedDBID | --- --K --M -RU .1- .55 .FO 0R~ 123 1B1 1P~ 1~5 29L 4.4 457 4CK 4G. 53G 5VS 6PF 7-5 71M 7RV 7X7 88E 8AO 8C1 8C2 8FI 8FJ AAEDT AAEDW AAIKJ AAKOC AALRI AAMRU AAQFI AAQQT AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABMAC ABMZM ABUWG ABWVN ACGFS ACIEU ACLOT ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADMUD ADNMO AEIPS AEKER AENEX AEUPX AEVXI AFKRA AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AHMBA AIGII AIIUN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BENPR BKEYQ BKOJK BNPGV BPHCQ BVXVI CCPQU CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-Q GBLVA HMCUK HVGLF HZ~ IHE J1W KOM M1P M41 MO0 N9A NAPCQ O-L O9- OC~ OO- OZT P-8 P-9 P2P PCD PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO R2- ROL RPZ SDG SEL SES SPCBC SSH SSZ T5K TLN UKHRP UV1 WOW X7M XBR Z5R ~HD 3V. AACTN AFCTW AFKWA AJOXV ALIPV AMFUW RIG SDF ABLVK ABYKQ AHPSJ AJBFU ZA5 9DU AAYXX AFFHD CITATION AGCQF AGRNS CGR CUY CVF ECM EIF NPM 7TO 7XB 8FK H94 K9. PKEHL PQEST PQUKI 7X8 ADTPV AOWAS D93 F1U |
| ID | FETCH-LOGICAL-c640t-49997fd0ba7dba935b6045b91ef37a3bdb6a660e44c895f1d5fab316318f988c3 |
| IEDL.DBID | 8C1 |
| ISICitedReferencesCount | 559 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000268153500010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1470-2045 1474-5488 |
| IngestDate | Tue Nov 04 16:37:58 EST 2025 Tue Nov 04 16:40:16 EST 2025 Tue Oct 21 13:42:21 EDT 2025 Tue Oct 07 05:18:31 EDT 2025 Mon Jul 21 06:03:53 EDT 2025 Tue Nov 18 22:09:32 EST 2025 Sat Nov 29 07:02:20 EST 2025 Fri Feb 23 02:29:55 EST 2024 Sun Feb 23 10:18:55 EST 2025 Tue Oct 14 19:34:42 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c640t-49997fd0ba7dba935b6045b91ef37a3bdb6a660e44c895f1d5fab316318f988c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| PMID | 19556163 |
| PQID | 200909870 |
| PQPubID | 46089 |
| PageCount | 10 |
| ParticipantIDs | swepub_primary_oai_gup_ub_gu_se_119376 swepub_primary_oai_DiVA_org_umu_25354 proquest_miscellaneous_67452007 proquest_journals_200909870 pubmed_primary_19556163 crossref_primary_10_1016_S1470_2045_09_70159_7 crossref_citationtrail_10_1016_S1470_2045_09_70159_7 elsevier_sciencedirect_doi_10_1016_S1470_2045_09_70159_7 elsevier_clinicalkeyesjournals_1_s2_0_S1470204509701597 elsevier_clinicalkey_doi_10_1016_S1470_2045_09_70159_7 |
| PublicationCentury | 2000 |
| PublicationDate | 2009-07-01 |
| PublicationDateYYYYMMDD | 2009-07-01 |
| PublicationDate_xml | – month: 07 year: 2009 text: 2009-07-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | The lancet oncology |
| PublicationTitleAlternate | Lancet Oncol |
| PublicationYear | 2009 |
| Publisher | Elsevier Ltd Elsevier Limited |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited |
| References | Waaler (bib16) 1984; 679 Williamson, Pamuk, Thun, Flanders, Byers, Heath (bib5) 1999; 149 Adams, Stroup, Gress (bib12) 2009; 17 Renehan, Frystyk, Flyvbjerg (bib28) 2006; 17 Preiss, Sattar (bib23) 2009; 70 Torgerson, Lindroos, Näslund, Peltonen (bib17) 2003; 98 Elliott, Aucott, Hannaford, Smith (bib9) 2005; 13 Le Roux, Welbourn, Werling (bib31) 2007; 246 Calle, Rodriguez, Walker-Thurmond, Thun (bib3) 2003; 348 Wee, McCarthy, Davis, Phillips (bib24) 2000; 132 Trentham-Dietz, Newcomb, Egan (bib10) 2000; 11 Parker, Folsom (bib6) 2003; 27 Sjöström, Larsson, Backman (bib13) 1992; 16 Rohan, Negassa, Caan (bib39) 2008; 1 Sjöström, Lönn, Chowdhury (bib21) 1996 Hansson, Gluckman (bib27) 2008; 102 Torgerson, Hauptman, Boldrin, Sjöström (bib34) 2004; 27 Barb, Williams, Neuwirth, Mantzoros (bib30) 2007; 86 McInnis (bib35) 2003; 18 Dirx, Zeegers, Dagnelie, van den Bogaard, van den Brandt (bib36) 2003; 106 Williamson, Pamuk, Thun, Flanders, Byers, Heath (bib4) 1995; 141 Christou, Lieberman, Sampalis, Sampalis (bib11) 2008; 4 Sjöström, Narbro, Sjöström (bib15) 2007; 357 Beresford, Johnson, Ritenbaugh (bib38) 2006; 295 Renehan, Tyson, Egger, Heller, Zwahlen (bib1) 2008; 371 Stunkard, McLaren-Hume (bib32) 1959; 79 Sjöström (bib26) 2008 Rodriguez, Freedland, Deka (bib8) 2007; 16 Cox (bib20) 1972; B50 Ogden, Yanovski, Carroll, Flegal (bib2) 2007; 132 Anand, Kunnumakkara, Sundaram (bib22) 2008; 25 Adams, Gress, Smith (bib25) 2007; 356 Glenny, O'Meara, Melville, Sheldon, Wilson (bib33) 1997; 21 Sjöström, Lindroos, Peltonen (bib14) 2004; 351 Pan, DesMeules (bib40) 2009; 472 Lindroos, Lissner, Sjöström (bib18) 1993; 47 Harvie, Howell, Vierkant (bib7) 2005; 14 Sjöström (bib19) 2000; 13 Prentice, Caan, Chlebowski (bib37) 2006; 295 Key, Appleby, Reeves (bib29) 2003; 95 Ogden (10.1016/S1470-2045(09)70159-7_bib2) 2007; 132 Wee (10.1016/S1470-2045(09)70159-7_bib24) 2000; 132 Sjöström (10.1016/S1470-2045(09)70159-7_bib19) 2000; 13 Williamson (10.1016/S1470-2045(09)70159-7_bib5) 1999; 149 Glenny (10.1016/S1470-2045(09)70159-7_bib33) 1997; 21 Adams (10.1016/S1470-2045(09)70159-7_bib25) 2007; 356 Prentice (10.1016/S1470-2045(09)70159-7_bib37) 2006; 295 Le Roux (10.1016/S1470-2045(09)70159-7_bib31) 2007; 246 Beresford (10.1016/S1470-2045(09)70159-7_bib38) 2006; 295 Torgerson (10.1016/S1470-2045(09)70159-7_bib17) 2003; 98 Barb (10.1016/S1470-2045(09)70159-7_bib30) 2007; 86 Lindroos (10.1016/S1470-2045(09)70159-7_bib18) 1993; 47 Christou (10.1016/S1470-2045(09)70159-7_bib11) 2008; 4 Sjöström (10.1016/S1470-2045(09)70159-7_bib26) 2008 Sjöström (10.1016/S1470-2045(09)70159-7_bib13) 1992; 16 Anand (10.1016/S1470-2045(09)70159-7_bib22) 2008; 25 Adams (10.1016/S1470-2045(09)70159-7_bib12) 2009; 17 Dirx (10.1016/S1470-2045(09)70159-7_bib36) 2003; 106 Sjöström (10.1016/S1470-2045(09)70159-7_bib15) 2007; 357 Pan (10.1016/S1470-2045(09)70159-7_bib40) 2009; 472 Stunkard (10.1016/S1470-2045(09)70159-7_bib32) 1959; 79 Rodriguez (10.1016/S1470-2045(09)70159-7_bib8) 2007; 16 Elliott (10.1016/S1470-2045(09)70159-7_bib9) 2005; 13 Hansson (10.1016/S1470-2045(09)70159-7_bib27) 2008; 102 Renehan (10.1016/S1470-2045(09)70159-7_bib28) 2006; 17 Torgerson (10.1016/S1470-2045(09)70159-7_bib34) 2004; 27 McInnis (10.1016/S1470-2045(09)70159-7_bib35) 2003; 18 Trentham-Dietz (10.1016/S1470-2045(09)70159-7_bib10) 2000; 11 Key (10.1016/S1470-2045(09)70159-7_bib29) 2003; 95 Sjöström (10.1016/S1470-2045(09)70159-7_bib21) 1996 Waaler (10.1016/S1470-2045(09)70159-7_bib16) 1984; 679 Preiss (10.1016/S1470-2045(09)70159-7_bib23) 2009; 70 Parker (10.1016/S1470-2045(09)70159-7_bib6) 2003; 27 Cox (10.1016/S1470-2045(09)70159-7_bib20) 1972; B50 Sjöström (10.1016/S1470-2045(09)70159-7_bib14) 2004; 351 Rohan (10.1016/S1470-2045(09)70159-7_bib39) 2008; 1 Renehan (10.1016/S1470-2045(09)70159-7_bib1) 2008; 371 Harvie (10.1016/S1470-2045(09)70159-7_bib7) 2005; 14 Williamson (10.1016/S1470-2045(09)70159-7_bib4) 1995; 141 Calle (10.1016/S1470-2045(09)70159-7_bib3) 2003; 348 19556164 - Lancet Oncol. 2009 Jul;10(7):640-1. doi: 10.1016/S1470-2045(09)70170-6. |
| References_xml | – volume: 17 start-page: 328 year: 2006 end-page: 336 ident: bib28 article-title: Obesity and cancer risk: the role of the insulin-IGF axis publication-title: Trends Endocrinol Metab – volume: 14 start-page: 656 year: 2005 end-page: 661 ident: bib7 article-title: Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study publication-title: Cancer Epidemiol Biomarkers Prev – volume: 25 start-page: 2097 year: 2008 end-page: 2116 ident: bib22 article-title: Cancer is a preventable disease that requires major lifestyle changes publication-title: Pharm Res – volume: B50 start-page: 225 year: 1972 end-page: 266 ident: bib20 article-title: Regression models and life-tables (with discussion) publication-title: J R Stat Soc – volume: 246 start-page: 780 year: 2007 end-page: 785 ident: bib31 article-title: Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass publication-title: Ann Surg – volume: 13 start-page: 213 year: 2000 end-page: 230 ident: bib19 article-title: Surgical intervention as a strategy for treatment of obesity publication-title: Endocrine – volume: 357 start-page: 741 year: 2007 end-page: 752 ident: bib15 article-title: Effects of bariatric surgery on mortality in Swedish Obese Subjects publication-title: N Engl J Med – volume: 98 start-page: 1032 year: 2003 end-page: 1041 ident: bib17 article-title: Gallstones, gallbladder disease, and pancreatitis: cross-sectional and 2-year data from the Swedish Obese Subjects (SOS) and SOS reference studies publication-title: Am J Gastroenterol – volume: 371 start-page: 569 year: 2008 end-page: 578 ident: bib1 article-title: Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies publication-title: Lancet – volume: 679 start-page: 1 year: 1984 end-page: 56 ident: bib16 article-title: Height, weight and mortality. The Norwegian experience publication-title: Acta Med Scand Suppl – volume: 95 start-page: 1218 year: 2003 end-page: 1226 ident: bib29 article-title: Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women publication-title: J Natl Cancer Inst – volume: 472 start-page: 191 year: 2009 end-page: 215 ident: bib40 article-title: Energy intake, physical activity, energy balance, and cancer: epidemiologic evidence publication-title: Methods Mol Biol – volume: 86 start-page: s858 year: 2007 end-page: s866 ident: bib30 article-title: Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence publication-title: Am J Clin Nutr – volume: 1 start-page: 275 year: 2008 end-page: 284 ident: bib39 article-title: Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trial publication-title: Cancer Prev Res – volume: 141 start-page: 1128 year: 1995 end-page: 1141 ident: bib4 article-title: Prospective study of intentional weight loss and mortality in never- smoking overweight US white women aged 40–64 years publication-title: Am J Epidemiol – volume: 21 start-page: 715 year: 1997 end-page: 737 ident: bib33 article-title: The treatment and prevention of obesity: a systematic review of the literature publication-title: Int J Obes Relat Metab Disord – start-page: 503 year: 2008 end-page: 515 ident: bib26 article-title: Swedish Obese Subjects: a review of results from a prospective controlled intervention trial publication-title: Handbook of Obesity – volume: 27 start-page: 1447 year: 2003 end-page: 1452 ident: bib6 article-title: Intentional weight loss and incidence of obesity-related cancers: the Iowa Women's Health Study publication-title: Int J Obes Relat Metab Disord – volume: 27 start-page: 155 year: 2004 end-page: 161 ident: bib34 article-title: Xenical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients publication-title: Diabetes Care – volume: 106 start-page: 766 year: 2003 end-page: 770 ident: bib36 article-title: Energy restriction and the risk of spontaneous mammary tumors in mice: a meta-analysis publication-title: Int J Cancer – volume: 4 start-page: 691 year: 2008 end-page: 695 ident: bib11 article-title: Bariatric surgery reduces cancer risk in morbidly obese patients publication-title: Surg Obes Relat Dis – volume: 16 start-page: 465 year: 1992 end-page: 479 ident: bib13 article-title: Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state publication-title: Int J Obes Relat Metab Disord – volume: 11 start-page: 533 year: 2000 end-page: 542 ident: bib10 article-title: Weight change and risk of postmenopausal breast cancer (United States) publication-title: Cancer Causes Control – volume: 79 start-page: 103 year: 1959 end-page: 118 ident: bib32 article-title: The results of treatment for obesity publication-title: Arch Intern Med – volume: 16 start-page: 63 year: 2007 end-page: 69 ident: bib8 article-title: Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort publication-title: Cancer Epidemiol Biomarkers Prev – start-page: 309 year: 1996 end-page: 319 ident: bib21 article-title: The sagittal diameter is a valid marker of visceral adipose tissue volume publication-title: Recent Advances in Obesity Research VII – volume: 132 start-page: 697 year: 2000 end-page: 704 ident: bib24 article-title: Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care? publication-title: Ann Intern Med – volume: 18 start-page: 93 year: 2003 end-page: 100 ident: bib35 article-title: Diet, exercise, and the challenge of combating obesity in primary care publication-title: J Cardiovasc Nurs – volume: 70 start-page: 815 year: 2009 end-page: 828 ident: bib23 article-title: Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence publication-title: Clin Endocrinol – volume: 356 start-page: 753 year: 2007 end-page: 761 ident: bib25 article-title: Long-term mortality following gastric bypass surgery publication-title: N Engl J Med – volume: 47 start-page: 461 year: 1993 end-page: 481 ident: bib18 article-title: Validity and reproducibility of a self-administered dietary questionnaire in obese and non-obese subjects publication-title: Eur J Clin Nutr – volume: 295 start-page: 643 year: 2006 end-page: 654 ident: bib38 article-title: Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial publication-title: JAMA – volume: 348 start-page: 1625 year: 2003 end-page: 1638 ident: bib3 article-title: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults publication-title: N Engl J Med – volume: 149 start-page: 491 year: 1999 end-page: 503 ident: bib5 article-title: Prospective study of intentional weight loss and mortality in overweight white men aged 40–64 years publication-title: Am J Epidemiol – volume: 295 start-page: 629 year: 2006 end-page: 642 ident: bib37 article-title: Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial publication-title: JAMA – volume: 351 start-page: 2683 year: 2004 end-page: 2693 ident: bib14 article-title: Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery publication-title: N Engl J Med – volume: 132 start-page: 2087 year: 2007 end-page: 2102 ident: bib2 article-title: The epidemiology of obesity publication-title: Gastroenterology – volume: 17 start-page: 796 year: 2009 end-page: 802 ident: bib12 article-title: Cancer incidence and mortality after gastric bypass surgery publication-title: Obesity – volume: 13 start-page: 1784 year: 2005 end-page: 1792 ident: bib9 article-title: Weight change in adult life and health outcomes publication-title: Obes Res – volume: 102 start-page: 90 year: 2008 end-page: 93 ident: bib27 article-title: Developmental origins of health and disease publication-title: Basic Clin Pharmacol Toxicol – volume: 132 start-page: 697 year: 2000 ident: 10.1016/S1470-2045(09)70159-7_bib24 article-title: Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care? publication-title: Ann Intern Med doi: 10.7326/0003-4819-132-9-200005020-00003 – volume: 13 start-page: 1784 year: 2005 ident: 10.1016/S1470-2045(09)70159-7_bib9 article-title: Weight change in adult life and health outcomes publication-title: Obes Res doi: 10.1038/oby.2005.217 – volume: 16 start-page: 63 year: 2007 ident: 10.1016/S1470-2045(09)70159-7_bib8 article-title: Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-06-0754 – volume: 11 start-page: 533 year: 2000 ident: 10.1016/S1470-2045(09)70159-7_bib10 article-title: Weight change and risk of postmenopausal breast cancer (United States) publication-title: Cancer Causes Control – volume: 79 start-page: 103 year: 1959 ident: 10.1016/S1470-2045(09)70159-7_bib32 article-title: The results of treatment for obesity publication-title: Arch Intern Med – volume: 4 start-page: 691 year: 2008 ident: 10.1016/S1470-2045(09)70159-7_bib11 article-title: Bariatric surgery reduces cancer risk in morbidly obese patients publication-title: Surg Obes Relat Dis doi: 10.1016/j.soard.2008.08.025 – volume: 357 start-page: 741 year: 2007 ident: 10.1016/S1470-2045(09)70159-7_bib15 article-title: Effects of bariatric surgery on mortality in Swedish Obese Subjects publication-title: N Engl J Med doi: 10.1056/NEJMoa066254 – volume: 348 start-page: 1625 year: 2003 ident: 10.1016/S1470-2045(09)70159-7_bib3 article-title: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults publication-title: N Engl J Med doi: 10.1056/NEJMoa021423 – volume: 95 start-page: 1218 year: 2003 ident: 10.1016/S1470-2045(09)70159-7_bib29 article-title: Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djg022 – volume: 25 start-page: 2097 year: 2008 ident: 10.1016/S1470-2045(09)70159-7_bib22 article-title: Cancer is a preventable disease that requires major lifestyle changes publication-title: Pharm Res doi: 10.1007/s11095-008-9661-9 – volume: 17 start-page: 328 year: 2006 ident: 10.1016/S1470-2045(09)70159-7_bib28 article-title: Obesity and cancer risk: the role of the insulin-IGF axis publication-title: Trends Endocrinol Metab doi: 10.1016/j.tem.2006.08.006 – volume: 246 start-page: 780 year: 2007 ident: 10.1016/S1470-2045(09)70159-7_bib31 article-title: Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass publication-title: Ann Surg doi: 10.1097/SLA.0b013e3180caa3e3 – volume: 18 start-page: 93 year: 2003 ident: 10.1016/S1470-2045(09)70159-7_bib35 article-title: Diet, exercise, and the challenge of combating obesity in primary care publication-title: J Cardiovasc Nurs doi: 10.1097/00005082-200304000-00004 – volume: 472 start-page: 191 year: 2009 ident: 10.1016/S1470-2045(09)70159-7_bib40 article-title: Energy intake, physical activity, energy balance, and cancer: epidemiologic evidence publication-title: Methods Mol Biol doi: 10.1007/978-1-60327-492-0_8 – volume: 70 start-page: 815 year: 2009 ident: 10.1016/S1470-2045(09)70159-7_bib23 article-title: Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence publication-title: Clin Endocrinol doi: 10.1111/j.1365-2265.2008.03490.x – volume: 21 start-page: 715 year: 1997 ident: 10.1016/S1470-2045(09)70159-7_bib33 article-title: The treatment and prevention of obesity: a systematic review of the literature publication-title: Int J Obes Relat Metab Disord doi: 10.1038/sj.ijo.0800495 – volume: 17 start-page: 796 year: 2009 ident: 10.1016/S1470-2045(09)70159-7_bib12 article-title: Cancer incidence and mortality after gastric bypass surgery publication-title: Obesity doi: 10.1038/oby.2008.610 – volume: 16 start-page: 465 year: 1992 ident: 10.1016/S1470-2045(09)70159-7_bib13 article-title: Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state publication-title: Int J Obes Relat Metab Disord – volume: 102 start-page: 90 year: 2008 ident: 10.1016/S1470-2045(09)70159-7_bib27 article-title: Developmental origins of health and disease publication-title: Basic Clin Pharmacol Toxicol doi: 10.1111/j.1742-7843.2007.00186.x – volume: 27 start-page: 155 year: 2004 ident: 10.1016/S1470-2045(09)70159-7_bib34 article-title: Xenical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients publication-title: Diabetes Care doi: 10.2337/diacare.27.1.155 – start-page: 309 year: 1996 ident: 10.1016/S1470-2045(09)70159-7_bib21 article-title: The sagittal diameter is a valid marker of visceral adipose tissue volume – volume: 1 start-page: 275 year: 2008 ident: 10.1016/S1470-2045(09)70159-7_bib39 article-title: Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trial publication-title: Cancer Prev Res doi: 10.1158/1940-6207.CAPR-08-0003 – volume: 295 start-page: 643 year: 2006 ident: 10.1016/S1470-2045(09)70159-7_bib38 article-title: Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial publication-title: JAMA doi: 10.1001/jama.295.6.643 – volume: 132 start-page: 2087 year: 2007 ident: 10.1016/S1470-2045(09)70159-7_bib2 article-title: The epidemiology of obesity publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.03.052 – volume: 356 start-page: 753 year: 2007 ident: 10.1016/S1470-2045(09)70159-7_bib25 article-title: Long-term mortality following gastric bypass surgery publication-title: N Engl J Med doi: 10.1056/NEJMoa066603 – volume: 86 start-page: s858 year: 2007 ident: 10.1016/S1470-2045(09)70159-7_bib30 article-title: Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence publication-title: Am J Clin Nutr doi: 10.1093/ajcn/86.3.858S – volume: 351 start-page: 2683 year: 2004 ident: 10.1016/S1470-2045(09)70159-7_bib14 article-title: Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery publication-title: N Engl J Med doi: 10.1056/NEJMoa035622 – volume: 371 start-page: 569 year: 2008 ident: 10.1016/S1470-2045(09)70159-7_bib1 article-title: Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies publication-title: Lancet doi: 10.1016/S0140-6736(08)60269-X – volume: 14 start-page: 656 year: 2005 ident: 10.1016/S1470-2045(09)70159-7_bib7 article-title: Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-04-0001 – volume: 98 start-page: 1032 year: 2003 ident: 10.1016/S1470-2045(09)70159-7_bib17 article-title: Gallstones, gallbladder disease, and pancreatitis: cross-sectional and 2-year data from the Swedish Obese Subjects (SOS) and SOS reference studies publication-title: Am J Gastroenterol – volume: B50 start-page: 225 year: 1972 ident: 10.1016/S1470-2045(09)70159-7_bib20 article-title: Regression models and life-tables (with discussion) publication-title: J R Stat Soc – volume: 13 start-page: 213 year: 2000 ident: 10.1016/S1470-2045(09)70159-7_bib19 article-title: Surgical intervention as a strategy for treatment of obesity publication-title: Endocrine doi: 10.1385/ENDO:13:2:213 – volume: 679 start-page: 1 year: 1984 ident: 10.1016/S1470-2045(09)70159-7_bib16 article-title: Height, weight and mortality. The Norwegian experience publication-title: Acta Med Scand Suppl – start-page: 503 year: 2008 ident: 10.1016/S1470-2045(09)70159-7_bib26 article-title: Swedish Obese Subjects: a review of results from a prospective controlled intervention trial – volume: 106 start-page: 766 year: 2003 ident: 10.1016/S1470-2045(09)70159-7_bib36 article-title: Energy restriction and the risk of spontaneous mammary tumors in mice: a meta-analysis publication-title: Int J Cancer doi: 10.1002/ijc.11277 – volume: 295 start-page: 629 year: 2006 ident: 10.1016/S1470-2045(09)70159-7_bib37 article-title: Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial publication-title: JAMA doi: 10.1001/jama.295.6.629 – volume: 27 start-page: 1447 year: 2003 ident: 10.1016/S1470-2045(09)70159-7_bib6 article-title: Intentional weight loss and incidence of obesity-related cancers: the Iowa Women's Health Study publication-title: Int J Obes Relat Metab Disord doi: 10.1038/sj.ijo.0802437 – volume: 149 start-page: 491 year: 1999 ident: 10.1016/S1470-2045(09)70159-7_bib5 article-title: Prospective study of intentional weight loss and mortality in overweight white men aged 40–64 years publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a009843 – volume: 141 start-page: 1128 year: 1995 ident: 10.1016/S1470-2045(09)70159-7_bib4 article-title: Prospective study of intentional weight loss and mortality in never- smoking overweight US white women aged 40–64 years publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a117386 – volume: 47 start-page: 461 year: 1993 ident: 10.1016/S1470-2045(09)70159-7_bib18 article-title: Validity and reproducibility of a self-administered dietary questionnaire in obese and non-obese subjects publication-title: Eur J Clin Nutr – reference: 19556164 - Lancet Oncol. 2009 Jul;10(7):640-1. doi: 10.1016/S1470-2045(09)70170-6. |
| SSID | ssj0017105 |
| Score | 2.5174613 |
| Snippet | Obesity is a risk factor for cancer. Intentional weight loss in the obese might protect against malignancy, but evidence is limited. To our knowledge, the... Summary Background Obesity is a risk factor for cancer. Intentional weight loss in the obese might protect against malignancy, but evidence is limited. To our... BACKGROUND: Obesity is a risk factor for cancer. Intentional weight loss in the obese might protect against malignancy, but evidence is limited. To our... |
| SourceID | swepub proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 653 |
| SubjectTerms | Adult Bariatric Surgery Cancer Case-Control Studies Endocrinology and Diabetes Endokrinologi och diabetes Energy Intake epidemiology Female Gastrointestinal surgery Hematology, Oncology and Palliative Medicine Humans Male Matched-Pair Analysis Middle Aged Mortality Multivariate Analysis Neoplasms Neoplasms - epidemiology Neoplasms - mortality Neoplasms - prevention & control Obesity Obesity - surgery Patients prevention & control Proportional Hazards Models Prospective Studies Sex Distribution surgery Sweden Sweden - epidemiology Ulcers Weight control Weight Loss Womens health |
| Title | Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1470204509701597 https://www.clinicalkey.es/playcontent/1-s2.0-S1470204509701597 https://dx.doi.org/10.1016/S1470-2045(09)70159-7 https://www.ncbi.nlm.nih.gov/pubmed/19556163 https://www.proquest.com/docview/200909870 https://www.proquest.com/docview/67452007 https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-25354 https://gup.ub.gu.se/publication/119376 |
| Volume | 10 |
| WOSCitedRecordID | wos000268153500010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1474-5488 dateEnd: 20251009 omitProxy: false ssIdentifier: ssj0017105 issn: 1470-2045 databaseCode: 7X7 dateStart: 20000901 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1474-5488 dateEnd: 20251009 omitProxy: false ssIdentifier: ssj0017105 issn: 1470-2045 databaseCode: 7RV dateStart: 20000901 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1474-5488 dateEnd: 20251009 omitProxy: false ssIdentifier: ssj0017105 issn: 1470-2045 databaseCode: BENPR dateStart: 20000901 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1474-5488 dateEnd: 20251009 omitProxy: false ssIdentifier: ssj0017105 issn: 1470-2045 databaseCode: 8C1 dateStart: 20000901 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jb9QwFLZoi1Av7MtQGHwA1EqEOpsdc0GltOLCULVQzc2yHXs6qEyG8QTET-Hf4hcnKYJCkbgkkZ0vm1_eYr8FocfSehlEde65H0mjzBYyUlybKFWl1GWivdALxSbYaFSMx_yg9c1xrVtlxxMbRl1WGubIt2EWn3gDmbycf46gaBQsrrYVNFbQWpyQDP7LYrf38IhZ8GCMM0YiyLp-FsCzfdQ3bhK-xbxM5BH7k2j6XfX8Ja9oI4v2r_3nW1xHV1slFO8EqrmBLpnZTXTlbbvMfgt9DzmNHa4sVt6YbtL4YxciqHE1wxpoZYFhnr6pSeqPcKWMM7jN0-qg5eir8b14E_ZTd4LfNWd4VvWxuTi4MH7beoEl9i_RRXw-w63z_Kkp8fQnh0zc1Be5jT7s773ffRO1NRwiTTOyjMCgYrYkSrJSSZ7mivqPrnhsbMqkpwhFJaXEZJkueG7jMrdSpV5JjAvLi0Knd9DqrJqZewhbm6dUMojk9VappCrLeWzzxCZSMirtAGXd8AndJjiHOhunovdkg1EXMOqCcNGMumAD9LyHzUOGj4sAtKMN0YWveoYrvAy6CMjOAxrXsg0nYuESQQIawIQ3UI8semSrGQWN519uutFRoujv05PhAD3qez1fgcUiOTNV7QRlGWTk8vi7gebPPg6Hkqo0HaAn4SfoeyBV-evp8Y6oFhNRf6pFkqd5NkBPzzlvUs-Fb5rUwhlvhnotmd7_66NuoPWwkgeu0g_Q6nJRm4fosv6ynLrFEK2ww2PYjlmzLYYNLxiitVd7o4PDH_cMYcs |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bT9RAFJ4gGvHFO7qiMg9iILHS60zHxBgCEgiwmoCGt3HazqxrcLvubCX8FH-E_9FzOm0xiuILDz61menXNtNz7ZwLIU-UAR3E8gSknx95sUmVl4lce1FWqLwIc1B6rtkE7_fTw0PxdoZ8b3NhMKyylYm1oC7KHP-Rr-JffB8cZP_V-IuHTaNwc7XtoOGoYkefHIPHZl9ub8DnXQrDzdcH61te01TAy1nsTz208Lkp_EzxIlMiSjIGVk0mAm0iruAVM6YY83Uc56lITFAkRmURWC1BakSa5hHc9xK5jIXs0NdL17uIkoC7iMkg5r6HVd5PE4ZW97vBZV-scNDBwuN_UoW_m7q_1DGtdd_mjf9s1W6S642RTdccV9wiM3p0m1zda8II7pBvrmazpaWhmZq4XiXUugxxWo5ojrwwobgPUfdchTNaZtpq2tShtTiyf6xhli7jcWg_0jf1FSCKP9U3xxDNk5UXVFFYtDaj9RltkgOOdEGHPwWc0rp_yl3y7kIWZp7MjsqRvk-oMUnEFMdMZfC6FcviRAQmCU2oFGfK9EjckovMmwLu2EfkSHaRekhlEqlM-kLWVCZ5jzzvYGNXweQ8AGtpUbbpuaBQJOjY84D8LKC2jVi0MpA2lL5DI9gXNRSQaYdsLD9n0f3LQxdaypfdczqy75HFbhbkJm6GqZEuKysZj7HiGODvOR47XRyBLWNZ1CNLjum6GSzFvjF8vybLyUBWnysZJlES98jTM64bVGMJQ4NKWg1uNngB7MFfX3WRzG0d7O3K3e3-zgK55nYtMSz8IZmdTir9iFzJv06HdvK4ljqUfLhohv0BW6K60A |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLZKQRUX9mUoUB8oaiXCZLVjJISqDiOqQqlUinozTmIPg8pkGE-o-lP4Kfw73ouTFEGhXHrglMjOl0TOW-O3EPJIGdBBLE9A-vmRF5tUeZnItRdlhcqLMAel55pN8J2d9OBA7C6Q720uDIZVtjKxFtRFmeM_8j7-xffBQfb7pomK2B0MX0y_eNhACjda224ajkK29fEReG_2-dYAPvVqGA5fvtt85TUNBrycxf7cQ2ufm8LPFC8yJaIkY2DhZCLQJuIKXjdjijFfx3GeisQERWJUFoEFE6RGpGkewX0vkIs8AiLGJPXNLrok4C56Moi572HF95Pkof5eN7jmi3UO-lh4_E9q8Xez95eaprUeHF79j1fwGrnSGN90w3HLdbKgJzfI0psmvOAm-eZqOVtaGpqpmethQq3LHKflhObIIzOK-xN1L1Y4o2WmraZNfVqLI3tHGmbpGh7H9iN9W18BIvpTfXMM3Txef0YVhQVsM12f0CZp4FAXdPxTICqt-6rcIvvnsjC3yeKknOi7hBqTRExxzGAGb1yxLE5EYJLQhEpxpkyPxC3pyLwp7I79RQ5lF8GHFCeR4qQvZE1xkvfI0w42dZVNzgKwli5lm7YLikaC7j0LyE8DatuISysDaUPpOzSCfVFDAZl2yMYidJbevzx0ueUC2T2nY4EeWelmQZ7iJpma6LKykvEYK5EB_o7jt5PFEdhKlkU9suoYsJvBEu2D8fsNWc5GsvpcyTCJkrhHHp9y3aiaShgaVdJqcL_BO2D3_vqqK2QJ-FS-3trZXiaX3WYmRovfJ4vzWaUfkEv51_nYzh7WAoiSD-fNrz8AcL3DlQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+bariatric+surgery+on+cancer+incidence+in+obese+patients+in+Sweden+%28Swedish+Obese+Subjects+Study%29%3A+a+prospective%2C+controlled+intervention+trial&rft.jtitle=The+lancet+oncology&rft.au=Sj%C3%B6str%C3%B6m%2C+Lars&rft.au=Gummesson%2C+Anders&rft.au=Sj%C3%B6str%C3%B6m%2C+C+David&rft.au=Narbro%2C+Kristina&rft.date=2009-07-01&rft.issn=1474-5488&rft.eissn=1474-5488&rft.volume=10&rft.issue=7&rft.spage=653&rft_id=info:doi/10.1016%2FS1470-2045%2809%2970159-7&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F14702045%2FS1470204509X71019%2Fcov150h.gif |